Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Stephen Blumberg

Clinical Cardiac Electrophysiology Dover, DE Medical Doctor

NPI 1396709440 CMS profile 630465

1113 S State St, Suite 100, Dover, DE 19901

Open in the dashboard

General payments

$27,997

215 records reported · program years 2019–2022

Research payments

$0

Paid to them · None reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Stephen Blumberg of Dover, DE is reported in the CMS Open Payments database as having received $27,997 across 215 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $16 1
2021 General $783 47
2020 General $9,577 71
2019 General $17,620 96

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Stephen Blumberg
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Stephen Blumberg were reported at $0. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Stephen Blumberg Clinical Cardiac Electrophysiology median Middle half National median
2019 $17,620 $2,361 $585–$8,260 $163
2020 $9,577 $993 $247–$4,351 $114
2021 $783 $1,185 $326–$4,739 $132
2022 $16 $2,073 $554–$6,789 $149
2023 $0 $2,568 $759–$8,159 $160
2024 $0 $2,557 $703–$7,403 $164
2025 $0 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Abbott Laboratories $25,498 60 payments
  2. Amgen Inc. $430 26 payments
  3. Janssen Pharmaceuticals, Inc $304 21 payments
  4. AstraZeneca Pharmaceuticals LP $275 19 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $146 10 payments
  6. Novartis Pharmaceuticals Corporation $145 9 payments
  7. Boston Scientific Corporation $136 12 payments
  8. E.R. Squibb & Sons, L.L.C. $128 7 payments
  9. Pfizer Inc. $122 8 payments
  10. Akcea Therapeutics, Inc. $109 3 payments
  11. Other $704 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Consulting Fee $24,108 31 payments
  2. Food and Beverage $3,847 182 payments
  3. Education $42 2 payments
Products named General payments · program years 2019–2022
  1. Allure Quadra RF CRT Pacemaker $8,859 12 payments
  2. Confirm Rx $6,254 16 payments
  3. Ensite Cardiac Mapping System $2,323 6 payments
  4. Merlin Connectivity and Remote $2,236 3 payments
  5. Endurity Pacemaker $2,008 2 payments
  6. Durata Defibrillation ICD Lead $2,008 2 payments
  7. Quadra Assura CRT Defibrillator $1,435 10 payments
  8. Repatha $414 25 payments
  9. Corlanor $380 23 payments
  10. XARELTO $304 21 payments
  11. Other $2,336 131 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

215 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record